Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Saraceno

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Epidemiology and Psychiatric Sciences|January 12, 2016
Social and environmental adversities, neurobiological processes and mental disordersC Barbui, B Saraceno
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: An effect size analysisC Barbui, B Saraceno
Revue Medicale Suisse|October 30, 2013
[Mental health and public health: an essential bond]B Saraceno, D Zullino
Epidemiology and Psychiatric Sciences|July 21, 2016
Global mental health: achievements, concerns and (unanswered) questionsB Saraceno, C Barbui
The International Journal of Social Psychiatry|January 1, 1989
Methodological lessons from the Italian psychiatric experienceB Saraceno, G Tognoni
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 21, 2001
Mental health and primary careJ Arboleda-Flórez, B Saraceno
Psychological Medicine|October 30, 1998
Antidepressant agents: from tricyclics to serotonin uptake inhibitorsS Garattini, C Barbui, B Saraceno
Archives of Neurology|December 15, 2000
A World Health Organization perspective on neurology and neuroscienceA Janca, L Prilipko, B Saraceno
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 23, 2001
[2001, a special year for mental health in the world]B Saraceno, J M Caldas de Almeida
Pharmacoepidemiology and Drug Safety|April 10, 2004
QUALYOP project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatientsC Barbui, B D'Avanzo, L Frattura, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Epidemiology and Psychiatric Sciences|January 12, 2016
Social and environmental adversities, neurobiological processes and mental disordersC Barbui, B Saraceno
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: An effect size analysisC Barbui, B Saraceno
Revue Medicale Suisse|October 30, 2013
[Mental health and public health: an essential bond]B Saraceno, D Zullino
Epidemiology and Psychiatric Sciences|July 21, 2016
Global mental health: achievements, concerns and (unanswered) questionsB Saraceno, C Barbui
The International Journal of Social Psychiatry|January 1, 1989
Methodological lessons from the Italian psychiatric experienceB Saraceno, G Tognoni
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 21, 2001
Mental health and primary careJ Arboleda-Flórez, B Saraceno
Psychological Medicine|October 30, 1998
Antidepressant agents: from tricyclics to serotonin uptake inhibitorsS Garattini, C Barbui, B Saraceno
Archives of Neurology|December 15, 2000
A World Health Organization perspective on neurology and neuroscienceA Janca, L Prilipko, B Saraceno
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 23, 2001
[2001, a special year for mental health in the world]B Saraceno, J M Caldas de Almeida
Pharmacoepidemiology and Drug Safety|April 10, 2004
QUALYOP project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatientsC Barbui, B D'Avanzo, L Frattura, et al.
Pageof 4